Jefferies files Form 144/A for Maplight Therapeutics

Jefferies LLC submitted a Form 144/A reporting proposed sales of Common Stock of Maplight Therapeutics, Inc. The filing is dated 04/15/2026 and references NASDAQ.

Rhea-AI Filing Summary

Jefferies LLC submitted a Form 144/A reporting proposed sales of Common Stock of Maplight Therapeutics, Inc. The filing is dated 04/15/2026 and references NASDAQ. It lists Restricted Stock Unit grants with explicit share counts: 07/30/2023 — 3,348 shares; 11/09/2023 — 1,545 shares; 05/02/2024 — 6,350 shares.

Insights

Securities Compliance Analyst

Filing is a routine resale notice by an affiliated broker-dealer listing RSU lots and a filing date.

The Form 144/A entry by Jefferies LLC lists specific Restricted Stock Unit grant dates and share counts, and carries the filing date 04/15/2026. This form notifies the market of intended resale activity under Rule 144 procedures.

Cash-flow treatment and exact resale amounts per transaction are not specified in the excerpt; subsequent trade reports or amended notices would show executed dispositions.

Key Figures

Filing date: 04/15/2026 RSU grant (07/30/2023): 3,348 shares RSU grant (11/09/2023): 1,545 shares +1 more

4 metrics

Filing date 04/15/2026 Form 144/A submission date shown in excerpt

RSU grant (07/30/2023) 3,348 shares Restricted Stock Unit grant listed in the filing

RSU grant (11/09/2023) 1,545 shares Restricted Stock Unit grant listed in the filing

RSU grant (05/02/2024) 6,350 shares Restricted Stock Unit grant listed in the filing

Key Terms

Restricted Stock Unit, Form 144/A, NASDAQ

3 terms

Restricted Stock Unit financial

"Restricted Stock Unit Grant | Maplight Therapeutics, Inc."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Form 144/A regulatory

"144/A: Filer Information"

NASDAQ market

"04/15/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Maplight Therapeutics (MPLT) Form 144/A filed by Jefferies LLC mean?

It notifies the SEC of proposed resale transactions in Maplight Therapeutics common stock. The filing lists RSU grant dates and share counts and is dated 04/15/2026 for NASDAQ-listed shares.

Which Restricted Stock Unit grants are listed in the MPLT Form 144/A?

The filing lists three RSU grants: 07/30/2023 — 3,348 shares; 11/09/2023 — 1,545 shares; 05/02/2024 — 6,350 shares. These are the explicit grant dates and counts shown in the excerpt.

Does the Form 144/A show completed sales of MPLT shares?

No. The Form 144/A excerpt shows proposed resale information and RSU grant counts; it does not report executed sale proceeds or post-sale holdings in the provided text.

Who filed the Form 144/A for MPLT and where is the filer located?

The filer is Jefferies LLC with an address listed as 520 Madison Avenue, 4th Floor, New York, NY 10022 in the excerpt. This identifies the broker-dealer submitting the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:53 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0002021233
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001974158-26-000044
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Foff Erin Pennock
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	3472	93813.44	42440000	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/30/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			3348	07/30/2023	N/A
Common	11/09/2023	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			1545	11/09/2023	N/A
Common	05/02/2024	Restricted Stock Unit Grant	Maplight Therapeutics, Inc.			6350	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax-withholding obligations in connection w/ RSU vesting.
Date of Notice	04/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Erin Foff
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)